New publication: CRyPTIC GWAS of antitubercular resistance Philip Fowler, 16th August 202216th August 2022 Since the primary goal of CRyPTIC was to map the genetic variants in M. tuberculosis associated with resistance to different antibiotics, this genome-wide association study is one of the key research outputs of the project. It brings together all the samples with genetic and drug susceptibility testing (DST) data and therefore relies on all the efforts to reduce the errors in the DST data, for example using AMyGDA to read the photographs of the 96-well plates and the efforts of the BashTheBug volunteers. In addition to associating genes already known to confer resistance to specific antibiotics, putative resistance genes are proposed for each of the thirteen drugs on the UKMYC series of broth microdilution plates. Danny Wilson and Sarah Earle led the GWAS analysis, which is complicated not only by the population structure (lineages) of M. tuberculosis but also by the fact that the resistance to each drug correlates with resistance to other drugs. Our involvement was mainly in improving the quality of the DST data, thereby improving the signal-to-noise ratio. Share this:TwitterBlueskyEmailLinkedInMastodon Related antimicrobial resistance clinical microbiology tuberculosis
New publication: determining novel mechanisms of bedaquiline resistance 30th March 20235th April 2023 A new paper with Lindsay Sonnenkalb as first-author has just been published in The Lancet… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
clinical microbiology New preprint: processing SARS-CoV-2 genetics in the cloud 31st January 202431st January 2024 In this preprint, we describe how in July 2022 for two weeks seven sites in… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
clinical microbiology New preprint: processing 3.9 million SARS-CoV-2 samples to make a consistent phylogenetic tree 7th May 20247th May 2024 Martin Hunt, Zam Iqbal and lots of others have written an epic preprint where they… Share this:TwitterBlueskyEmailLinkedInMastodon Read More